Nolan Vincent Chalifoux

Nolan Vincent Chalifoux

Auto-generated profile, based on publicly available information

Nolan Vincent Chalifoux

University of Pennsylvania, School of Veterinary Medicine Department of Clinical Sciences & Advanced Medicine Philadelphia, Pennsylvania

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
NCNolan V. Chalifoux
Nolan V. Chalifoux
SPSarah E. Parker
Sarah E. Parker
KCKevin L. Cosford
Kevin L. Cosford

1 January 2023 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
NCNolan V. Chalifoux
Nolan V. Chalifoux
EBEmmanuelle M. Butty
Emmanuelle M. Butty
KMKatie D. Mauro
Katie D. Mauro
RMRachel B. Moyle
Rachel B. Moyle
CECaryn M. Ehrhardt
Caryn M. Ehrhardt
ALAlex Lynch
Alex Lynch
Background: Traditional management of non-steroidal anti-inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are popular novel therapeutic strategies. Hypothesis: Compare outcomes of dogs treated with IVF, ILE, and TPE for NSAID intoxications and evaluate outcome predictors for drug subgroups. Animals: Four hundred thirty-four dogs with NSAID intoxications (2015-2020). Methods: Multicenter retrospective study of ibuprofen, carprofen, and naproxen intoxication. An ordinal outcome was defined as mild gastrointestinal, moderate kidney, or signs of severe central nervous system disease. Results: Signs of neurological disease were overrepresented and acute kidney injury underrepresented in the TPE group among dogs exposed to kidney- or CNS-toxic doses (P = .05), though all TPE dogs with signs of neurological disease had evidence of neurotoxicity at presentation. Dogs treated with IVF had a higher maximal creatinine concentration (median, 1.1 mg/dL; range, 0.4-8.44 mg/dL) compared with IVF + ILE (median, 0.9 mg/dL; range, 0.4-6.2 mg/dL; P = .01). Increased maximum time to presentation (P < .001), higher baseline creatinine (P < .001) and PCV (P = .007), and absence of induced emesis (P < .001) were associated with greater clinical severity. Ibuprofen toxicosis was associated with more severe clinical signs compared with carprofen (P = .03). Overall survival rate was 99%. Conclusions and Clinical Importance: NSAID toxicosis generally carries an excellent prognosis in dogs. Despite similar outcomes of lower incidence of AKI in the TPE group, and slightly lower maximal creatinine concentration in dogs treated with ILE vs IVF alone, ILE and TPE should be considered in the management of severe NSAID toxicosis.

5 August 2022 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
EBEmmanuelle M. Butty
Emmanuelle M. Butty
SSSteven E. Suter
Steven E. Suter
NCNolan V. Chalifoux
Nolan V. Chalifoux
ALAlex Lynch
Alex Lynch
KMKatie D. Mauro
Katie D. Mauro
MLMary Anna Labato
Mary Anna Labato
Background: Therapeutic plasma exchange (TPE) is gaining popularity for the management of nonsteroidal anti-inflammatory drug (NSAID) overdose in dogs. Hypothesis/Objectives: Describe a population of dogs treated with TPE for NSAID overdose. Animals: Sixty-two dogs with NSAID overdose treated with TPE. Methods: Multicenter retrospective study of dogs treated with TPE for ibuprofen, carprofen, or naproxen overdose. Results: The median dose of ibuprofen, carprofen or naproxen ingested was 533 mg/kg (range, 36-4857 mg/kg), 217 mg/kg (range, 88-625 mg/kg) and 138 mg/kg (range, 26-3000 mg/kg), respectively. Based on previously established toxic ranges for each NSAID, 2 (3.2%), 14 (22.6%), and 46 (74.2%) dogs ingested a gastrointestinal, renal, and neurological toxic dose, respectively. The median time between ingestion and presentation was 4 hours (range, 1-20 hours). The median number of plasma volumes processed was 1.6 (range, 0.4-2.2). The median TPE session duration was 2 hours (range, 1-4.5 hours). Circuit clotting developed during 8 (12.9%) sessions. Patient adverse events reported during 21 (33.8%) sessions consisted of urticaria (12.9%), asymptomatic hypocalcemia (9.6%), and hypotension (9.6%). The median duration of hospitalization was 2.25 days (range, 1-11 days). Sixty-one (98.4%) dogs survived to discharge, and none were rehospitalized. Thirty-one (91.1%) of the 34 dogs with at least 1 follow-up visit were not azotemic at the time of reevaluation. Conclusions and Clinical Importance: This population of dogs managed with TPE had excellent outcomes, even in cases of high NSAID dose ingestion. When TPE is available and the time frame is appropriate, this extracorporeal modality should be considered for the management of NSAID overdose.

29 May 2024 in Neurocritical Care
Verified
Journal Article
Open access
PDF file
NCNolan Chalifoux
Nolan Chalifoux
Tiffany S. KoTiffany S. Ko
Tiffany S. Ko
JSJulia Slovis
Julia Slovis
ASAudrey Spelde
Audrey Spelde
TKTodd J Kilbaugh
Todd J Kilbaugh
CMConstantine D. Mavroudis
Constantine D. Mavroudis
Despite improvements in survival after illnesses requiring extracorporeal life support, cerebral injury continues to hinder successful outcomes. Cerebral autoregulation (CA) is an innate protective mechanism that maintains constant cerebral blood flow in the face of varying systemic blood pressure. However, it is impaired in certain disease states and, potentially, following initiation of extracorporeal circulatory support. In this review, we first discuss patient-related factors pertaining to venovenous and venoarterial extracorporeal membrane oxygenation (ECMO) and their potential role in CA impairment. Next, we examine factors intrinsic to ECMO that may affect CA, such as cannulation, changes in pulsatility, the inflammatory and adaptive immune response, intracranial hemorrhage, and ischemic stroke, in addition to ECMO management factors, such as oxygenation, ventilation, flow rates, and blood pressure management. We highlight potential mechanisms that lead to disruption of CA in both pediatric and adult populations, the challenges of measuring CA in these patients, and potential associations with neurological outcome. Altogether, we discuss individualized CA monitoring as a potential target for improving neurological outcomes in extracorporeal life support.

1 June 2023 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
YBYekaterina Buriko
Yekaterina Buriko
NCNolan V. Chalifoux
Nolan V. Chalifoux
RCRachel Clarkin‐Breslin
Rachel Clarkin‐Breslin
DSDeborah C. Silverstein
Deborah C. Silverstein

20 May 2021 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
NCNolan V. Chalifoux
Nolan V. Chalifoux
RHRebecka S. Hess
Rebecka S. Hess
DSDeborah C Silverstein
Deborah C Silverstein